Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1988 Dec;74(3):404–408.

Eosinophilic gastroenteritis: ultrastructural evidence for a selective release of eosinophil major basic protein.

G Torpier 1, J F Colombel 1, C Mathieu-Chandelier 1, M Capron 1, J P Dessaint 1, A Cortot 1, J C Paris 1, A Capron 1
PMCID: PMC1542005  PMID: 3233790

Abstract

Ultrastructural study of mucosal eosinophils in a case of eosinophilic gastroenteritis involving stomach, duodenum and ileum showed an altered structure in ulcerated duodenal areas. The electron core density of eosinophil granules was inverted or disappeared and tubulovesicular structures occurred. Using immunogold staining with specific antibodies, major basic protein was detected diffusely in the matrix of eosinophil granules and out of the granules in tight association with extragranular membrane formations. In contrast, eosinophil cationic protein and eosinophil peroxidase were normally distributed in the granule matrix. When compared with the eosinophils in macroscopically normal duodenal mucosa in the same patient, these changes support a role for major basic protein in tissue damage in eosinophilic gastroenteritis. The diffusion of one granule protein from the granules to the exterior of the cells favours the view of a selective release of eosinophil mediators.

Full text

PDF
404

Images in this article

405Fig. 1
on p.405
406Fig. 2
on p.406

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Butterworth A. E., Wassom D. L., Gleich G. J., Loegering D. A., David J. R. Damage to schistosomula of Schistosoma mansoni induced directly by eosinophil major basic protein. J Immunol. 1979 Jan;122(1):221–229. [PubMed] [Google Scholar]
  2. Capron M., Kusnierz J. P., Prin L., Spiegelberg H. L., Ovlaque G., Gosset P., Tonnel A. B., Capron A. Cytophilic IgE on human blood and tissue eosinophils: detection by flow microfluorometry. J Immunol. 1985 May;134(5):3013–3018. [PubMed] [Google Scholar]
  3. Capron M., Spiegelberg H. L., Prin L., Bennich H., Butterworth A. E., Pierce R. J., Ouaissi M. A., Capron A. Role of IgE receptors in effector function of human eosinophils. J Immunol. 1984 Jan;132(1):462–468. [PubMed] [Google Scholar]
  4. Dvorak A. M. Ultrastructural evidence for release of major basic protein-containing crystalline cores of eosinophil granules in vivo: cytotoxic potential in Crohn's disease. J Immunol. 1980 Jul;125(1):460–462. [PubMed] [Google Scholar]
  5. Frigas E., Loegering D. A., Gleich G. J. Cytotoxic effects of the guinea pig eosinophil major basic protein on tracheal epithelium. Lab Invest. 1980 Jan;42(1):35–43. [PubMed] [Google Scholar]
  6. Gleich G. J., Frigas E., Loegering D. A., Wassom D. L., Steinmuller D. Cytotoxic properties of the eosinophil major basic protein. J Immunol. 1979 Dec;123(6):2925–2927. [PubMed] [Google Scholar]
  7. Keshavarzian A., Saverymuttu S. H., Tai P. C., Thompson M., Barter S., Spry C. J., Chadwick V. S. Activated eosinophils in familial eosinophilic gastroenteritis. Gastroenterology. 1985 Apr;88(4):1041–1049. doi: 10.1016/s0016-5085(85)80026-3. [DOI] [PubMed] [Google Scholar]
  8. Khalife J., Capron M., Cesbron J. Y., Tai P. C., Taelman H., Prin L., Capron A. Role of specific IgE antibodies in peroxidase (EPO) release from human eosinophils. J Immunol. 1986 Sep 1;137(5):1659–1664. [PubMed] [Google Scholar]
  9. Kierszenbaum F., Ackerman S. J., Gleich G. J. Destruction of bloodstream forms of Trypanosoma cruzi by eosinophil granule major basic protein. Am J Trop Med Hyg. 1981 Jul;30(4):775–779. doi: 10.4269/ajtmh.1981.30.775. [DOI] [PubMed] [Google Scholar]
  10. Kroegel C., Costabel U., Matthys H. Mechanism of membrane damage mediated by eosinophil major basic protein. Lancet. 1987 Jun 13;1(8546):1380–1381. doi: 10.1016/s0140-6736(87)90686-6. [DOI] [PubMed] [Google Scholar]
  11. Peters M. S., Rodriguez M., Gleich G. J. Localization of human eosinophil granule major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin by immunoelectron microscopy. Lab Invest. 1986 Jun;54(6):656–662. [PubMed] [Google Scholar]
  12. Prin L., Capron M., Tonnel A. B., Bletry O., Capron A. Heterogeneity of human peripheral blood eosinophils: variability in cell density and cytotoxic ability in relation to the level and the origin of hypereosinophilia. Int Arch Allergy Appl Immunol. 1983;72(4):336–346. doi: 10.1159/000234893. [DOI] [PubMed] [Google Scholar]
  13. Roth J., Bendayan M., Carlemalm E., Villiger W., Garavito M. Enhancement of structural preservation and immunocytochemical staining in low temperature embedded pancreatic tissue. J Histochem Cytochem. 1981 May;29(5):663–671. doi: 10.1177/29.5.6166664. [DOI] [PubMed] [Google Scholar]
  14. Sparrevohn S., Wulff H. R. The nuclear segmentation of eosinophils under normal and pathological conditions. Acta Haematol. 1967;37(2):120–125. doi: 10.1159/000209059. [DOI] [PubMed] [Google Scholar]
  15. Tai P. C., Ackerman S. J., Spry C. J., Dunnette S., Olsen E. G., Gleich G. J. Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease. Lancet. 1987 Mar 21;1(8534):643–647. doi: 10.1016/s0140-6736(87)90412-0. [DOI] [PubMed] [Google Scholar]
  16. Tai P. C., Capron M., Bakes D. M., Barkans J., Spry C. J. Monoclonal antibodies to human eosinophil plasma membrane antigens enhance the secretion of eosinophil cationic protein. Clin Exp Immunol. 1986 Mar;63(3):728–737. [PMC free article] [PubMed] [Google Scholar]
  17. Tai P. C., Spry C. J., Peterson C., Venge P., Olsson I. Monoclonal antibodies distinguish between storage and secreted forms of eosinophil cationic protein. Nature. 1984 May 10;309(5964):182–184. doi: 10.1038/309182a0. [DOI] [PubMed] [Google Scholar]
  18. Wassom D. L., Gleich G. J. Damage to Trichinella spiralis newborn larvae by eosinophil major basic protein. Am J Trop Med Hyg. 1979 Sep;28(5):860–863. [PubMed] [Google Scholar]
  19. Weiss S. J., Test S. T., Eckmann C. M., Roos D., Regiani S. Brominating oxidants generated by human eosinophils. Science. 1986 Oct 10;234(4773):200–203. doi: 10.1126/science.3018933. [DOI] [PubMed] [Google Scholar]
  20. Young J. D., Peterson C. G., Venge P., Cohn Z. A. Mechanism of membrane damage mediated by human eosinophil cationic protein. Nature. 1986 Jun 5;321(6070):613–616. doi: 10.1038/321613a0. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES